NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group

RecruitingNA

Sponsor: University Hospital, Bordeaux

Conditions: Multiple Sclerosis

Interventions: Anti-Mullerian hormone (AMH) level, Antral follicle count (AFC), Clinical assessment

Countries: France

The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.

Eligibility overview

Sex: FEMALE

Age: 25 Years to 35 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* Reproductive women between 25 and 35 years old ;
* MS Patient : Diagnosis of multiple sclerosis based on McDonald Criteria 2017;
* French-speaking, without comprehension disorders ;
* being affiliated to health insurance ;
* Willing to participate and to sign informed consent.

Exclusion Criteria:

* History of ovarian surgery (cystectomy, annexectomy) ;
* Turner Syndrome ;
* fragile X messenger ribonucleoprotein 1 (FMR1) premutation ;
* Endometriosis with a risk of ovarian reserve alteration ;
* History of chemotherapy or pelvic radiotherapy ;
* Pregnant or breastfeeding women ;
* patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).

Locations (1)

Bordeaux, France